Scientific Knowledge Hub & Research Library

8-week double-blind RCT (n=101) demonstrated a 57% reduction on the ABC Irritability Subscale with risperidone vs. 14% with placebo (P < 0.001). Weight gain and metabolic monitoring are clinically essential.

8-week randomized trial (n=218, ages 5–17) established efficacy at 5mg, 10mg, and 15mg doses. Mean ABC-I improvements were clinically significant vs placebo. Lower incidence of hyperprolactinemia relative to risperidone.

Comprehensive evidence-based synthesis. Pharmacotherapy should only be considered when psychosocial interventions are insufficient or in acute crises. High emphasis on routine monitoring for metabolic and extrapyramidal effects.

Double-blind, placebo-controlled crossover Phase II trial (n=180, ages 2–7). A single infusion of autologous or allogeneic cord blood yielded no statistically significant difference from placebo on the primary outcome (VABS-3 Socialization). Post-hoc subgroup signals in IQ > 70 require further validation.

Meta-analysis of available trials highlighted severe heterogeneity, small sample sizes, publication bias, and strong placebo effects. The International Society for Stem Cell Research (ISSCR) and FDA caution against commercial, unproven stem cell therapies for ASD.

Cochrane review synthesizing 5 RCTs and non-randomized studies (n=219). Found moderate-to-low quality evidence that EIBI increases adaptive behavior, IQ, and receptive/expressive language compared to treatment-as-usual.

RCT of toddlers (aged 18–30 months, n=48). Children receiving ESDM demonstrated significant improvements in IQ (mean gain 17.6 points vs 7.0 points in community group), receptive/expressive language, and adaptive behavior, representing the emergence of NDBIs.

Comprehensive network meta-analysis of 133 double-blind RCTs in children/adolescents (n=14,346). Methylphenidate was identified as the preferred first-line pharmacological treatment for children and adolescents when considering both efficacy (SMD -0.78) and tolerability.

Gold-standard multicenter trial (n=579, ages 7–9.9). Compared medication management, intensive behavioral treatment, combined treatment, and community care. Combined treatment yielded superior consumer satisfaction and required 20% lower stimulant dosages.

Sequential multiple assignment randomized trial (SMART design, n=146). Initiating intervention with behavioral parent training and school accommodations resulted in fewer classroom rule violations, lower medication requirements, and superior cost-effectiveness compared to starting with medication first.

AAP Clinical Practice Guideline. Explicitly designates Parent Training in Behavior Management (PTBM) and behavioral classroom interventions as primary first-line for preschool-aged children before psychopharmacology is considered.

Neuroimaging and MEG studies confirm atypical temporal auditory cortical processing and thalamocortical filtering deficits in ASD, formally integrated into DSM-5 Criterion B.4 (hyper/hyporeactivity to sensory input).

Comparative analysis of sensory modulation across cohorts. ADHD sensory seeking is linked to central hypo-arousal and executive regulation needs, while ASD sensory patterns show distinct bimodal distributions of extreme avoidance and under-responsiveness.

AAP formal policy statement. Concluded that Sensory Processing Disorder (SPD) should not be diagnosed as an isolated standalone medical condition; sensory symptoms must be evaluated within the context of comprehensive developmental and behavioral assessments.

Dunn's ecological sensory model establishes neurological thresholds (high vs. low) crossed with behavioral self-regulation (passive vs. active), providing a normative continuum for assessing sensory styles in typical and neurodivergent children.

Barkley’s theoretical model posits behavioral inhibition as the primary deficit that impacts four second-order executive functions: nonverbal working memory, internalization of speech, self-regulation of affect/arousal, and reconstitution.

Dual-pathway model dissociates the dorsal meso-cortical circuit (mediating executive inhibitory dysregulation) from the ventral meso-limbic dopamine circuit (mediating motivational delay aversion and altered reward processing).

Delphi consensus with 59 international experts established clinical criteria for DLD, retiring misleading terms such as "Specific Language Impairment (SLI)" and clarifying boundaries with ASD and social communication disorders.

Cochrane review synthesizing 33 RCTs. Demonstrated that targeted speech-language therapy yields large positive effect sizes for expressive phonology and syntax; parent-implemented language training showed comparable efficacy to clinician-delivered therapy in early intervention.

Open codebase and research pipeline integrating actigraphy, sleep mat pressure arrays, EEG, and standardized Sensory Profile questionnaires for autistic vs neurotypical sibling cohorts.

PyTorch and MobileNetV3 architecture trained on facial action units to detect prodromal autonomic arousal and sensory overload, allowing parents/educators to initiate co-regulation early.

Graph neural network (GNN) implementation trained on resting-state fMRI from the ABIDE and ADHD-200 open repositories, modeling whole-brain functional connectivity fingerprints.

Tabular dataset featuring standardized Q-CHAT (Quantitative Checklist for Autism in Toddlers) items, social responsiveness indicators, and developmental milestone variables.

Acoustic models trained on pediatric speech corpora addressing high fundamental frequency (F0), formant dispersion shifts, and developmental phonological reductions compared to adult speech models.